NO167801C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.Info
- Publication number
- NO167801C NO167801C NO864695A NO864695A NO167801C NO 167801 C NO167801 C NO 167801C NO 864695 A NO864695 A NO 864695A NO 864695 A NO864695 A NO 864695A NO 167801 C NO167801 C NO 167801C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogue procedure
- imidazold
- derivatives
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80145885A | 1985-11-25 | 1985-11-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO864695D0 NO864695D0 (no) | 1986-11-24 |
| NO167801B NO167801B (no) | 1991-09-02 |
| NO167801C true NO167801C (no) | 1991-12-11 |
Family
ID=25181154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO864695A NO167801C (no) | 1985-11-25 | 1986-11-24 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0229922B1 (fr) |
| JP (1) | JPS62135461A (fr) |
| KR (1) | KR900000671B1 (fr) |
| CN (1) | CN86108027A (fr) |
| AT (1) | ATE74912T1 (fr) |
| AU (1) | AU585409B2 (fr) |
| CA (1) | CA1286301C (fr) |
| DE (1) | DE3684900D1 (fr) |
| DK (1) | DK562686A (fr) |
| ES (1) | ES2036520T3 (fr) |
| FI (1) | FI864751A (fr) |
| GR (1) | GR3004386T3 (fr) |
| HU (1) | HU205087B (fr) |
| IL (1) | IL80733A0 (fr) |
| NO (1) | NO167801C (fr) |
| NZ (1) | NZ218354A (fr) |
| PH (1) | PH22526A (fr) |
| PT (1) | PT83799B (fr) |
| ZA (1) | ZA868809B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839375A (en) * | 1987-07-28 | 1989-06-13 | Merrell Dow Pharmaceuticals Inc. | (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents |
| US7322704B2 (en) | 2004-07-30 | 2008-01-29 | Novalux, Inc. | Frequency stabilized vertical extended cavity surface emitting lasers |
| JP4935090B2 (ja) * | 2006-01-31 | 2012-05-23 | ソニー株式会社 | 半導体発光装置 |
| CN101676293B (zh) * | 2008-09-18 | 2012-11-21 | 宁波大学 | 一种联咪唑有机膦化合物及其制备方法 |
| CN102304089A (zh) * | 2011-07-01 | 2012-01-04 | 中国科学院过程工程研究所 | 一种4,4′,5,5′-四硝基-2,2′-联咪唑的合成方法 |
-
1986
- 1986-11-20 CA CA000523502A patent/CA1286301C/fr not_active Expired - Lifetime
- 1986-11-20 ZA ZA868809A patent/ZA868809B/xx unknown
- 1986-11-20 PH PH34501A patent/PH22526A/en unknown
- 1986-11-21 AT AT86116131T patent/ATE74912T1/de not_active IP Right Cessation
- 1986-11-21 DE DE8686116131T patent/DE3684900D1/de not_active Expired - Fee Related
- 1986-11-21 EP EP86116131A patent/EP0229922B1/fr not_active Expired - Lifetime
- 1986-11-21 NZ NZ218354A patent/NZ218354A/xx unknown
- 1986-11-21 AU AU65565/86A patent/AU585409B2/en not_active Ceased
- 1986-11-21 ES ES198686116131T patent/ES2036520T3/es not_active Expired - Lifetime
- 1986-11-21 FI FI864751A patent/FI864751A/fi not_active Application Discontinuation
- 1986-11-24 DK DK562686A patent/DK562686A/da not_active Application Discontinuation
- 1986-11-24 IL IL80733A patent/IL80733A0/xx not_active IP Right Cessation
- 1986-11-24 PT PT83799A patent/PT83799B/pt not_active IP Right Cessation
- 1986-11-24 HU HU864855A patent/HU205087B/hu not_active IP Right Cessation
- 1986-11-24 KR KR1019860009901A patent/KR900000671B1/ko not_active IP Right Cessation
- 1986-11-24 NO NO864695A patent/NO167801C/no unknown
- 1986-11-25 CN CN198686108027A patent/CN86108027A/zh active Pending
- 1986-11-25 JP JP61278925A patent/JPS62135461A/ja active Pending
-
1992
- 1992-04-16 GR GR920400542T patent/GR3004386T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO167801B (no) | 1991-09-02 |
| ES2036520T3 (es) | 1993-06-01 |
| IL80733A0 (en) | 1987-02-27 |
| EP0229922A3 (en) | 1988-03-30 |
| NO864695D0 (no) | 1986-11-24 |
| HUT42075A (en) | 1987-06-29 |
| ZA868809B (en) | 1987-07-29 |
| FI864751A (fi) | 1987-05-26 |
| DK562686A (da) | 1987-05-26 |
| DK562686D0 (da) | 1986-11-24 |
| AU585409B2 (en) | 1989-06-15 |
| PT83799B (pt) | 1988-08-17 |
| EP0229922A2 (fr) | 1987-07-29 |
| KR870004977A (ko) | 1987-06-02 |
| CA1286301C (fr) | 1991-07-16 |
| PH22526A (en) | 1988-10-17 |
| NZ218354A (en) | 1989-09-27 |
| EP0229922B1 (fr) | 1992-04-15 |
| KR900000671B1 (ko) | 1990-02-02 |
| GR3004386T3 (fr) | 1993-03-31 |
| CN86108027A (zh) | 1987-10-07 |
| AU6556586A (en) | 1987-05-28 |
| PT83799A (en) | 1986-12-01 |
| ATE74912T1 (de) | 1992-05-15 |
| HU205087B (en) | 1992-03-30 |
| JPS62135461A (ja) | 1987-06-18 |
| DE3684900D1 (de) | 1992-05-21 |
| FI864751A0 (fi) | 1986-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO165542C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO164972C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. |